Profil
Philip Morgan is currently the President & Director at Corhythm, Inc., the President at Fe3 Medical, Inc., and the Vice President-San Antonio at InCube Labs LLC.
Previously, he worked as the Director at NeuroTherapeutics Pharma, Inc., the Principal at GlaxoSmithKline Research & Development, and as an Advisor-Preclinical Research at Jenken Biosciences, Inc. He also served as a Venture Partner at ePlanet Capital Advisors US, Inc. in 2010.
Dr. Morgan holds an MBA from Duke University and a doctorate from the University of London.
Postes actifs de Philip Morgan
| Sociétés | Poste | Début |
|---|---|---|
Corhythm, Inc.
 Corhythm, Inc. Pharmaceuticals: MajorHealth Technology Corhythm, Inc. develops devices for the treatment of atrial fibrillation. The firm offers device that uses semiconductor technology to provide pacing and defibrillation and delivers targeted medications when an atrial fibrillation is detected. The company was founded by Mir Imran in 2007 and is headquartered in San Antonio, TX. | President | - |
Fe3 Medical, Inc.
 Fe3 Medical, Inc. Medical SpecialtiesHealth Technology Fe3 Medical, Inc. develops a transdermal therapy for iron deficiency anemia. It offers a disposable transdermal patch that delivers the amount of iron needed directly through the skin, bypassing the GI tract and eliminating undesirable side effects. The company was founded by Mir A. Imran in 2008 and is headquartered in San Antonio, TX. | President | - |
InCube Labs LLC
 InCube Labs LLC Medical SpecialtiesHealth Technology InCube Labs LLC provides therapeutic services and medical devices. It offers treatment to central nervous system, cardiovascular disease, metabolic diseases, micronutrient deficiency, and gastrointestinal end-stage renal disease cancer. The company was founded on February 22, 2007 and is headquartered in San Jose, CA. | Corporate Officer/Principal | - |
Anciens postes connus de Philip Morgan
| Sociétés | Poste | Fin |
|---|---|---|
ePlanet Capital Advisors US, Inc.
 ePlanet Capital Advisors US, Inc. Investment ManagersFinance ePlanet Capital Advisors US Inc (ePlanet Capital) is a venture capital firm founded in 1999 by Asad Jamal. The firm is headquartered in San Jose, California. | Directeur/Membre du Conseil | 22/06/2010 |
NeuroTherapeutics Pharma, Inc.
 NeuroTherapeutics Pharma, Inc. Pharmaceuticals: MajorHealth Technology NeuroTherapeutics Pharma, Inc. is a biopharmaceutical company focused on developing therapies for diseases associated with central nervous system hyper-excitability. It is developing compounds that decrease or eliminate aberrant excitatory discharges by working through a new mechanism of action. The firm's proprietary molecules target a novel molecular site that will create a pipeline of potential new treatments for multiple CNS disorders. The company's lead compound, NTP-2014, has exhibited excellent efficacy results in multiple preclinical models of epilepsy, acute and neuropathic pain. NeuroTherapeutics Pharma was founded in 2006 and is headquartered in Chicago, IL. | Directeur/Membre du Conseil | - |
Jenken Biosciences, Inc.
 Jenken Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Jenken Biosciences, Inc. operated as a pharmaceutical company. It specialized in the development and commercialization of small molecules as toll-like receptor 4 (TLR4) antagonists. The company was founded by Edwin Wu in 2003 and was headquartered in Durham, NC. | Corporate Officer/Principal | - |
GlaxoSmithKline Research & Development
 GlaxoSmithKline Research & Development Pharmaceuticals: MajorHealth Technology GlaxoSmithKline Research & Development manufactures pharmaceutical products. It has locations in the U.S. and across Europe. The company has treatments in the works for therapies such as infectious diseases, neuroscientific requirements and respiratory needs. GlaxoSmithKline is located in Research Triangle Park, NC | Corporate Officer/Principal | - |
Formation de Philip Morgan
| Duke University | Masters Business Admin |
| University of London | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Corhythm, Inc.
Corhythm, Inc. Pharmaceuticals: MajorHealth Technology Corhythm, Inc. develops devices for the treatment of atrial fibrillation. The firm offers device that uses semiconductor technology to provide pacing and defibrillation and delivers targeted medications when an atrial fibrillation is detected. The company was founded by Mir Imran in 2007 and is headquartered in San Antonio, TX. | Health Technology |
Fe3 Medical, Inc.
Fe3 Medical, Inc. Medical SpecialtiesHealth Technology Fe3 Medical, Inc. develops a transdermal therapy for iron deficiency anemia. It offers a disposable transdermal patch that delivers the amount of iron needed directly through the skin, bypassing the GI tract and eliminating undesirable side effects. The company was founded by Mir A. Imran in 2008 and is headquartered in San Antonio, TX. | Health Technology |
GlaxoSmithKline Research & Development
GlaxoSmithKline Research & Development Pharmaceuticals: MajorHealth Technology GlaxoSmithKline Research & Development manufactures pharmaceutical products. It has locations in the U.S. and across Europe. The company has treatments in the works for therapies such as infectious diseases, neuroscientific requirements and respiratory needs. GlaxoSmithKline is located in Research Triangle Park, NC | Health Technology |
ePlanet Capital Advisors US, Inc.
ePlanet Capital Advisors US, Inc. Investment ManagersFinance ePlanet Capital Advisors US Inc (ePlanet Capital) is a venture capital firm founded in 1999 by Asad Jamal. The firm is headquartered in San Jose, California. | Finance |
NeuroTherapeutics Pharma, Inc.
NeuroTherapeutics Pharma, Inc. Pharmaceuticals: MajorHealth Technology NeuroTherapeutics Pharma, Inc. is a biopharmaceutical company focused on developing therapies for diseases associated with central nervous system hyper-excitability. It is developing compounds that decrease or eliminate aberrant excitatory discharges by working through a new mechanism of action. The firm's proprietary molecules target a novel molecular site that will create a pipeline of potential new treatments for multiple CNS disorders. The company's lead compound, NTP-2014, has exhibited excellent efficacy results in multiple preclinical models of epilepsy, acute and neuropathic pain. NeuroTherapeutics Pharma was founded in 2006 and is headquartered in Chicago, IL. | Health Technology |
Jenken Biosciences, Inc.
Jenken Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Jenken Biosciences, Inc. operated as a pharmaceutical company. It specialized in the development and commercialization of small molecules as toll-like receptor 4 (TLR4) antagonists. The company was founded by Edwin Wu in 2003 and was headquartered in Durham, NC. | Health Technology |
InCube Labs LLC
InCube Labs LLC Medical SpecialtiesHealth Technology InCube Labs LLC provides therapeutic services and medical devices. It offers treatment to central nervous system, cardiovascular disease, metabolic diseases, micronutrient deficiency, and gastrointestinal end-stage renal disease cancer. The company was founded on February 22, 2007 and is headquartered in San Jose, CA. | Health Technology |
